P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study.

Research output: Contribution to journalArticle

  • External authors:
  • Rayid Abdulqawi
  • Gary Layton
  • Bruce G. McCarthy
  • Anthony P. Ford

Bibliographical metadata

Original languageEnglish
Pages (from-to)1198-1205
Number of pages7
JournalThe Lancet
Issue number9974
Publication statusPublished - 28 Mar 2015